preclinics Italia is now officially accredited under the French Crédit d’Impôt Recherche (CIR) and Crédit d’Impôt Innovation (CII) schemes as an approved R&D service provider.
This means that eligible French companies can benefit from up to 30% tax credit on qualifying R&D activities outsourced to preclinics Italia.
Our accredited services include:
- Single domain antibody (VHH) development, engineering, and library screening
- Recombinant protein and antibody expression in E. coli and yeast
- Custom assay development and antibody modification strategies
Partner with a certified CRO to accelerate your research while optimizing your R&D investment.
Contact us: italia@preclinics.com